Turf work continues in Lafourche
July 5, 2018
Lockport man found with narcotics and thousands in cash
July 5, 2018
The Mary Bird Perkins TGMC Cancer Center is the only facility in the region offering a new, innovative tool proven to protect prostate cancer patients from side effects that can result from radiation therapy.
The Cancer Center is now using SpaceOAR hydrogel, which is the first FDA cleared temporary spacing device to protect vital organs in men being treated for the disease.
The gel creates space between the prostate and rectum and has been shown to reduce bowel and rectal reactions.
Before this technology, prostate cancer patients may have had a balloon put in their rectum to protect their organs during radiation treatment. The balloon was placed prior to each radiation dose, but SpaceOar is a temporary gel and only needs to be injected once.
“With the addition of SpaceOAR, prostate cancer patience can now receive treatment in a more comfortable and effective way,” said Dr. Daniel Bourgeois, a Radiation Oncologist at the Cancer Center. “Most patients do not even feel the gel in their bodies, allowing them to focus on what’s important – beating cancer and getting back to their lives.”
